Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > x sites, y patients, always underwhelming

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Nov 09, 2023 10:49am

121 Views

Post# 35726048

RE:RE:RE:RE:x sites, y patients, always underwhelming

You're the one espousing the "party" line, not I. So I think you are the shill ( how ironic is that)

I'm just stating what could/ should happen ( in order to save thousands of lives)

In any case, I'm sure that Baxter has some good statisticians on board... so the 90/150 debate might be a red herring

MM

<< Previous

Bullboard Posts

Next >>

Cybin launches new program phase to treat Major Depressive Disorder